Article ; Online: Assays for Validating Histone Acetyltransferase Inhibitors.
Journal of visualized experiments : JoVE
2020 , Issue 162
Abstract: Lysine acetyltransferases (KATs) catalyze acetylation of lysine residues on histones and other proteins to regulate chromatin dynamics and gene expression. KATs, such as CBP/p300, are under intense investigation as therapeutic targets due to their ... ...
| Abstract | Lysine acetyltransferases (KATs) catalyze acetylation of lysine residues on histones and other proteins to regulate chromatin dynamics and gene expression. KATs, such as CBP/p300, are under intense investigation as therapeutic targets due to their critical role in tumorigenesis of diverse cancers. The development of novel small molecule inhibitors targeting the histone acetyltransferase (HAT) function of KATs is challenging and requires robust assays that can validate the specificity and potency of potential inhibitors. This article outlines a pipeline of three methods that provide rigorous in vitro validation for novel HAT inhibitors (HATi). These methods include a test tube HAT assay, Chromatin Hyperacetylation Inhibition (ChHAI) assay, and Chromatin Immunoprecipitation-quantitative PCR (ChIP-qPCR). In the HAT assay, recombinant HATs are incubated with histones in a test tube reaction, allowing for acetylation of specific lysine residues on the histone tails. This reaction can be blocked by a HATi and the relative levels of site-specific histone acetylation can be measured via immunoblotting. Inhibitors identified in the HAT assay need to be confirmed in the cellular environment. The ChHAI assay uses immunoblotting to screen for novel HATi that attenuate the robust hyperacetylation of histones induced by a histone deacetylase inhibitor (HDACi). The addition of an HDACi is helpful because basal levels of histone acetylation can be difficult to detect via immunoblotting. The HAT and ChHAI assays measure global changes in histone acetylation, but do not provide information regarding acetylation at specific genomic regions. Therefore, ChIP-qPCR is used to investigate the effects of HATi on histone acetylation levels at gene regulatory elements. This is accomplished through selective immunoprecipitation of histone-DNA complexes and analysis of the purified DNA through qPCR. Together, these three assays allow for the careful validation of the specificity, potency, and mechanism of action of novel HATi. |
|---|---|
| MeSH term(s) | Acetylation/drug effects ; Anacardic Acids/pharmacology ; Biological Assay/methods ; Cyclin D1/genetics ; Cyclin D1/metabolism ; E1A-Associated p300 Protein/antagonists & inhibitors ; E1A-Associated p300 Protein/metabolism ; Heterocyclic Compounds, 4 or More Rings/pharmacology ; Histone Acetyltransferases/metabolism ; Histone Deacetylase Inhibitors/pharmacology ; Histones/metabolism ; Humans ; Lysine/metabolism ; MCF-7 Cells ; Promoter Regions, Genetic/genetics ; Reproducibility of Results ; Sonication |
| Chemical Substances | A-485 compound ; Anacardic Acids ; Heterocyclic Compounds, 4 or More Rings ; Histone Deacetylase Inhibitors ; Histones ; Cyclin D1 (136601-57-5) ; anacardic acid (18654-18-7) ; E1A-Associated p300 Protein (EC 2.3.1.48) ; EP300 protein, human (EC 2.3.1.48) ; Histone Acetyltransferases (EC 2.3.1.48) ; Lysine (K3Z4F929H6) |
| Language | English |
| Publishing date | 2020-08-06 |
| Publishing country | United States |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Video-Audio Media |
| ZDB-ID | 2259946-0 |
| ISSN | 1940-087X ; 1940-087X |
| ISSN (online) | 1940-087X |
| ISSN | 1940-087X |
| DOI | 10.3791/61289 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.